848410-13-9

Basic information

• Product Name: tert-butyl octahydropyrrolo[3,2-c]pyridine-1-carboxylate
• Synonyms: tert-butyl octahydropyrrolo[3,2-c]pyridine-1-carboxylate;TERT-BUTYL OCTAHYDRO-1H-PYRROLO[3,2-C]PYRIDINE-1-CARBOXYLATE;1-Boc-Octahydropyrrolo[3,2-c]pyridine;1-Boc-Octahydropyrrolo[3,...;(3aR,7aS)-rel-tert-Butyl octahydro-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;(3aR,7aS)-rel-Octahydro-1H-pyrrolo[3,2-c]pyridine-1-carboxylic acid 1,1-dimethylethyl ester
• CAS NO: 848410-13-9
• Molecular Formula: C12H22N2O2
• Molecular Weight: 226.31528
• Mol File: 848410-13-9.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl octahydropyrrolo[3,2-c]pyridine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl octahydropyrrolo[3,2-c]pyridine-1-carboxylate(848410-13-9)
• EPA Substance Registry System: tert-butyl octahydropyrrolo[3,2-c]pyridine-1-carboxylate(848410-13-9)

Safety Data

• Hazardous Substances Data: 848410-13-9(Hazardous Substances Data)

Usage

General Description

Tert-butyl octahydropyrrolo[3,2-c]pyridine-1-carboxylate is a chemical compound with the molecular formula C14H25NO2. It is a derivative of octahydropyrrolo[3,2-c]pyridine, which is a bicyclic nitrogen-containing compound. The tert-butyl group is a common substituent in organic chemistry, adding bulk and steric hindrance to molecules. The carboxylate group indicates that this compound is an ester, with the carbon atom of the carboxylate group bonded to a tert-butyl group. tert-butyl octahydropyrrolo[3,2-c]pyridine-1-carboxylate may have applications in drug development, as it contains a heterocyclic ring and a carboxylate group, both of which are common structural motifs in pharmaceuticals. Further research may be necessary to determine the specific properties and potential uses of tert-butyl octahydropyrrolo[3,2-c]pyridine-1-carboxylate.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 271-34-1 5-azaindole 
• 148760-75-2 tert-butyl 1H-pyrrolo[3,2-c]pyridine-1-carboxylate 
• 1147421-99-5 5-benzyl-octahydro-pyrrolo[3,2-c]pyridine-1-carboxylic acid tert-butyl ester 
• 1074-98-2 3-methyl-4-nitropyridine N-oxide 
• 123367-22-6 (E)-N,N-dimethyl-2-(4-nitro-1-oxidopyridin-3-yl)ethenamine 

Relevant articles and documents

PYRROLO[2,3-B]PYRIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER

The present application relates to a compound of Formula I, or a salt, hydrate or solvate thereof, as defined herein. The present compounds are found to have pharmacological effects, particularly at MRCK. Further provided are pharmaceutical compositions comprising said compounds. The present invention also relates to the use of these compounds as therapeutic agents, in particular, for the treatment and/or prevention of proliferative diseases, such as cancer.

AMINOQUINAZOLINE DERIVATIVES AND THEIR SALTS AND METHODS OF USE

The present invention relates to the field of medicine. Provided herein are aminoquinazoline derivatives, their salts and pharmaceutical formulations useful in modulating the protein tyrosine kinase activity, and in modulating inter-and/or intra-cellular signaling. Also provided herein are pharmaceutically acceptable compositions comprising the aminoquinazoline compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.

Heterobicyclic pyrazole compounds and methods of use

Compounds of Formulas Ia and Ib, and stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting receptor tyrosine kinases and for treating disorders mediated thereby. Methods of using compounds of Formula Ia and Ib, and stereoisomers, geometric isomers, tautomers, solvates and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.